Inspire Medical Systems, Inc. revised financial guidance for the full year 2024. For the period, the company expects revenue to between $783 million to $793 million, which represents growth of 25% to 27% over full year 2023 revenue of $624.8 million. This compares to the prior revenue guidance of $775 million to $785 million.

The company is initiating first-time diluted net income per share guidance for the full year 2024 of between $0.10 to $0.20 per share.